Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Latest Healthcare AI Tools Should Prove Valued Assets for Resource-Limited Settings

Artificial intelligence is reshaping diagnostic capabilities in underserved regions where medical expertise and equipment remain scarce

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Arpita Hazra · Ai ToolsArpita HazraDermassistGoogle Health
Share

Key takeaways

01

Artificial intelligence is reshaping diagnostic capabilities in underserved regions where medical expertise and equipment remain scarce

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Recent studies show a significant increase in CT and ultrasound examinations over the past decade. GE's recent awarding of a $44 million grant from the Bill & Melinda Gates Foundation to develop AI-assisted ultrasound technology aims to enhance user-friendliness and improve healthcare outcomes, especially in low to middle-income countries. Additionally, AI tools like DermAssist by Google Health are emerging, allowing users to upload skin condition photos for analysis, indicating the potential of healthcare AI tools in direct patient care and as clinical decision-making support systems.

Can emerging healthcare AI tools, like GE's handheld ultrasound and Google's DermAssist, transcend skepticism to become trusted extensions of clinical practice?

Arpita Hazra, MD, MPH, Clinical Patient Safety Data Specialist at Healthcare Risk Advisors, emphasizes the potential of these tools to revolutionize care, especially in resource-limited settings.

I see that eventually, this tool can do a lot for us if it works the way it promises.
— Arpita Hazra, MD, MPH, Clinical Patient Safety Data Specialist at Healthcare Risk Advisors

Dr. Hazra said, underscoring the critical need for reliability, consistency, and integration in healthcare innovation.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Arpita Hazra
Arpita HazraClinical Patient Safety Data Specialist

Arpita Hazra, a dedicated physician, combines her medical expertise with a passion for building AI and machine learning models aimed at enhancing patient outcomes. Her boundless energy and unwavering motivation are evident in her multifaceted career. With a profound understanding of clinical data management, health education, public health, and program planning, Arpita has excelled in various domains including project management, patient safety, and risk analysis. Her versatility extends to healthcare consulting and clinical risk consulting, where she brings a wealth of qualitative and quantitative research experience to the table. Arpita is a force in healthcare business development, equipped with technical skills in Power BI, Azure Databricks, SQL, and SAS programming. Her expertise also encompasses healthcare data model architecture development and user acceptance testing (UAT), as well as medical writing. In essence, Arpita Hazra is a well-rounded professional with a mission to bridge medicine and technology for the betterment of patient care and outcomes.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

Arpita Hazra
Arpita Hazra

Clinical Patient Safety Data Specialist

Arpita Hazra, a dedicated physician, combines her medical expertise with a passion for building AI and machine learning models aimed at enhancing patient outcomes. Her boundless energy and unwavering motivation are evident in her multifaceted career. With a profound understanding of clinical data management, health education, public health, and program planning, Arpita has excelled in various domains including project management, patient safety, and risk analysis. Her versatility extends to healthcare consulting and clinical risk consulting, where she brings a wealth of qualitative and quantitative research experience to the table. Arpita is a force in healthcare business development, equipped with technical skills in Power BI, Azure Databricks, SQL, and SAS programming. Her expertise also encompasses healthcare data model architecture development and user acceptance testing (UAT), as well as medical writing. In essence, Arpita Hazra is a well-rounded professional with a mission to bridge medicine and technology for the betterment of patient care and outcomes.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512